Ann M. Bailey et al. found reduced FXR expression in early colon cancer owing to DNA methylation of the FXR promoter and enhanced Kirsten rat sarcoma viral oncogene (KRAS) signaling. The gene discussed is NR1H4; the disease is malignant colon neoplasm.